Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Sale of the Company's entire minority investment in Diagnosis S.A. (78,750 shares) to purchasers including Mr. Irani.
Secured promissory term note issued by the Company to Mr. Irani bearing 8% interest and maturing May 29, 2027, secured by the Diagnosis S.A. shares.
Purchased 31,250 shares in the August 2026 Private Placement at $1.60 per share.
Purchased 20,000 shares in the August 2026 Private Placement at $1.60 per share.
Purchased 6,250 shares in the August 2026 Private Placement at $1.60 per share.
Purchased 31,250 shares in the August 2026 Private Placement at $1.60 per share.
Purchased 10,000 shares in the August 2026 Private Placement at $1.60 per share.
Loading...
